About
Tamrisa develops new classes of antibiotics to combat antimicrobial resistance, focusing on novel chemical entities to treat multi-drug resistant bacterial infections, and also manages a portfolio of proven antibiotics for global distribution.
Explore Tamrisa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.